Advertisement
Screener

NIAGEN BIOSCIENCE, INC. (NAGE) Graph

NAGE Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $29.79M; Cost of revenue $10.47M; Research and development $1.51M; Operating expenses $18.61M.
  • 2026-03-31: Revenue $31.47M; Cost of revenue $11.50M; Research and development $1.48M; Operating expenses $18.40M.
  • 2025-12-31: Revenue $33.84M*; Cost of revenue $12.13M*; Research and development $1.71M*; Operating expenses $17.62M*.
  • 2025-09-30: Revenue $33.99M; Cost of revenue $12.06M; Research and development $1.79M; Operating expenses $17.69M.

Consolidation item

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

NAGE revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Corporate AndReconciling Items$236.00KRevenue$29.78MCost of revenue$10.47MGross profit$19.31MOperating expenses$18.61MOperating income$700.00KResearch & development$1.51MPre-tax income$1.07MIncome tax$106.00KNet income$963.00K

Segment

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

NAGE revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Analytical ReferenceStandards And Services Segment$0.00ConsumerProducts Segment$24.16MCorporate AndReconciling Items$236.00KIngredients Segment$5.39MRevenue$29.78MCost of revenue$10.47MGross profit$19.31MOperating expenses$18.61MOperating income$700.00KResearch & development$1.51MPre-tax income$1.07MIncome tax$106.00KNet income$963.00K

Subsegments

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

NAGE revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Food Grade NIAGEN$4.93MNIAGEN Related$29.52MOther GoodsAnd Services$270.00KOther Ingredients$25.00KPharmaceuticalGrade NIAGEN$425.00KReference Standards$0.00Services And Other$245.00KTRUNIAGENConsumer Product$24.16MRevenue$29.78MCost of revenue$10.47MGross profit$19.31MOperating expenses$18.61MOperating income$700.00KResearch & development$1.51MPre-tax income$1.07MIncome tax$106.00KNet income$963.00K

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30$29.79M$10.47M$1.51M$18.61M$106.00K$963.00K
2026-03-31$31.47M$11.50M$1.48M$18.40M$417.00K$6.32M
2025-12-31$33.84M*$12.13M*$1.71M*$17.62M*$292.00K*$4.13M*
2025-09-30$33.99M$12.06M$1.79M$17.69M$222.00K$4.58M
2025-06-30$31.12M$10.89M$1.57M$17.04M$128.00K$3.61M
2025-03-31$30.48M$11.15M$1.26M$14.56M$168.00K$5.06M
2024-09-30$25.58M$9.34M$1.29M$14.64M$0.00$1.88M
2024-06-30$22.74M$9.05M$1.32M$13.95M$0.00-$15.00K
2024-03-31$22.15M$8.70M$2.10M$14.19M$0.00-$492.00K
2023-09-30$19.50M$7.53M$1.24M$13.12M(m)-$959.00K
2023-06-30$20.32M$7.97M$1.36M$14.67M(m)-$2.19M
2023-03-31$22.56M$9.04M$1.19M$15.49M(m)-$1.90M
2022-09-30$17.06M$6.86M$1.22M$13.27M(m)-$985.00K
2022-06-30$16.73M$6.69M$1.25M$16.43M(m)-$6.40M
2022-03-31$17.26M$6.73M$1.08M$18.26M(m)-$7.74M
2021-09-30$17.31M$6.73M$996.00K$19.42M(m)-$8.86M
2021-06-30$17.70M$6.89M$1.00M$16.36M(m)-$5.57M
2021-03-31$14.68M$5.45M$787.00K$16.60M(m)-$7.38M
2020-09-30$14.18M$5.73M$841.00K$12.65M(m)-$4.21M
2020-06-30$15.29M$6.20M$895.00K$12.78M(m)-$3.71M
2020-03-31$14.35M$6.03M$919.00K$14.20M(m)-$5.90M
2019-09-30$12.05M$5.30M$1.04M$13.64M(m)-$7.20M
2019-06-30$11.10M$4.85M$1.07M$13.43M(m)-$7.75M
2019-03-31$10.05M$4.75M$1.17M$13.67M(m)-$8.34M
2018-09-30$8.12M$3.76M$1.35M$12.96M(m)-$8.61M
2018-06-30$7.80M$3.96M$1.41M$11.78M(m)-$8.05M
2018-03-31$6.57M$3.43M$1.44M$11.54M(m)-$8.44M
2017-12-30(m)(m)(m)$12.61M$0.00*-$8.82M
2017-09-30$6.08M$3.17M$1.04M$6.09M(m)$2.14M
2017-07-01$4.22M$2.11M$850.00K$4.76M$0.00-$2.76M
2017-04-01$0.00$1.75M$664.00K$3.39M$0.00-$1.93M
2016-12-31(m)(m)(m)$4.18M$3.50K-$2.15M
2016-10-01(m)$2.07M$772.80K$2.79M$3.15K-$954.39K
2016-07-02(m)$4.70M$751.73K$3.51M$4.09K-$82.67K
2016-04-02(m)$3.88M$464.07K$2.81M-$10.74K$255.63K
2016-01-02(m)(m)(m)$2.84M$4.53K-$1.43M
2015-10-03(m)$3.81M$188.69K$2.30M$0.00-$3.72K
2015-07-04(m)$3.63M$175.41K$2.65M$0.00-$315.19K
2015-04-04(m)$3.33M$121.09K$2.83M$0.00-$1.03M
2015-01-03(m)(m)(m)$2.52M(m)-$1.23M
2014-09-27(m)$2.62M(m)$2.17M(m)-$659.65K
2014-06-28(m)$2.46M(m)$3.04M(m)-$1.65M
2014-03-29(m)$2.09M(m)$2.82M(m)-$1.85M
2013-12-28(m)(m)(m)$1.46M(m)-$724.32K
2013-09-28(m)$1.97M(m)$1.99M(m)-$1.25M
2013-06-29(m)(m)(m)$1.97M(m)-$1.02M
2013-03-30(m)$1.66M(m)$2.09M(m)-$1.42M
2012-09-29(m)$2.38M(m)$2.79M(m)-$1.54M
2012-06-30(m)$1.91M(m)$4.75M(m)-$3.99M
2012-03-31(m)$2.39M(m)$3.82M(m)-$4.43M
2011-10-01$1.83M$1.36M(m)$2.86M(m)-$2.40M
2011-07-02$1.94M$1.36M(m)$2.42M(m)-$1.84M
2011-04-02(m)$1.52M(m)$2.17M(m)-$1.16M
2010-10-02$1.56M$1.06M(m)$1.38M(m)-$883.22K
2010-07-03$2.03M$1.26M(m)$1.07M(m)-$303.53K

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30$61.26M$21.97M$2.99M$37.01M$523.00K$7.28M
2025-06-30$61.60M$22.04M$2.83M$31.60M$296.00K$8.67M
2024-06-30$44.89M$17.74M$3.41M$28.14M$0.00-$507.00K
2023-06-30$42.88M$17.00M$2.56M$30.16M(m)-$4.09M
2022-06-30$33.99M$13.42M$2.32M$34.69M(m)-$14.14M
2021-06-30$32.38M$12.34M$1.79M$32.96M(m)-$12.95M
2020-06-30$29.63M$12.23M$1.70M$26.98M(m)-$9.61M
2019-06-30$21.15M$9.59M$2.24M$27.11M(m)-$16.09M
2018-06-30$14.37M$7.39M$2.85M$23.32M(m)-$16.49M
2017-07-01$7.59M$3.86M$1.51M$8.15M$0.00-$4.69M
2016-07-02(m)$8.58M$1.22M$6.75M$6.65K$172.96K
2015-07-04(m)$6.96M$296.50K$5.49M(m)-$1.34M
2014-06-28(m)$4.55M(m)$5.86M(m)-$3.50M
2013-06-29(m)$3.41M(m)$4.06M(m)-$2.44M
2012-06-30(m)$4.30M(m)$8.57M(m)-$8.43M
2011-07-02$4.48M$2.88M(m)$4.58M(m)-$3.00M
2010-07-03$3.97M$2.38M(m)$1.85M(m)-$269.79K

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2025-09-30$95.58M$34.10M$4.62M$49.29M$518.00K$13.25M
2024-09-30$70.47M$27.08M$4.70M$42.77M$0.00$1.37M
2023-09-30$62.37M$24.53M$3.80M$43.27M(m)-$5.05M
2022-09-30$51.05M$20.27M$3.55M$47.97M(m)-$15.12M
2021-09-30$49.69M$19.07M$2.79M$52.38M(m)-$21.80M
2020-09-30$43.81M$17.96M$2.54M$39.63M(m)-$13.83M
2019-09-30$33.20M$14.90M$3.28M$40.74M(m)-$23.29M
2018-09-30$22.49M$11.15M$4.20M$36.28M(m)-$25.10M
2017-09-30$13.67M$7.03M$2.55M$14.24M$0.00-$2.56M
2016-10-01(m)$8.83M$1.99M$9.11M-$3.50K-$781.43K
2015-10-03(m)$10.77M$485.19K$7.79M$0.00-$1.34M
2014-09-27(m)$7.16M(m)$8.03M(m)-$4.16M
2013-09-28(m)$5.38M(m)$6.06M(m)-$3.70M
2012-09-29(m)$6.67M(m)$11.36M(m)-$9.96M
2011-10-01$6.30M$4.24M(m)$7.45M(m)-$5.40M
2010-10-02$5.53M$3.44M(m)$3.22M(m)-$1.15M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2025-12-31$129.42M$46.23M$6.33M$66.91M$810.00K$17.38M
2024-12-31$99.60M$38.01M$6.02M$53.86M$305.00K$8.55M
2023-12-31$83.57M$32.79M$4.96M$56.38M$0.00-$4.94M
2022-12-31$72.05M$29.25M$4.83M$61.42M(m)-$16.54M
2021-12-31$67.45M$25.96M$3.83M$68.56M(m)-$27.13M
2020-12-31$59.26M$23.98M$3.42M$55.13M(m)-$19.93M
2019-12-31$46.29M$20.52M$4.42M$57.07M(m)-$32.15M
2018-12-31$31.56M$15.50M$5.48M$49.23M(m)-$33.32M
2017-12-30$21.20M$10.72M$4.01M$26.85M$0.00-$11.38M
2016-12-31(m)$11.27M$2.52M$13.30M$0.00-$2.93M
2016-01-02(m)$10.35M$891.60K$9.60M-$4.53K-$2.77M
2015-01-03(m)$9.99M$513.67K$10.56M$0.00-$5.39M
2013-12-28(m)$7.03M$134.04K$7.52M(m)-$4.42M
2012-12-29(m)$9.34M$142.00K$13.91M(m)-$11.66M
2011-12-31(m)$5.64M$96.79K$10.34M(m)-$7.89M
2011-01-01(m)$4.62M(m)$4.96M(m)-$2.05M

Similar stocks

Stock NameCountryMarket CapPE Ratio
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
Canopy Growth Corp (CGC)$0.395B
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87